Week Ending July 28th, 2023
Biotech: 1 Transaction (1 Follow-On) totaling just over $50 Million
Med Tech: 1 Transaction (1 Registered Direct) totaling just under $50 Million
2023 YTD
103 Biotech transactions totaling just over $14 Billion v. 2022: 77 Biotech transactions totaling just under $9 Billion
11 Med Tech transactions totaling just over $700 Million v. 2022: 6 Med Tech transaction just over $400 Million
Private Transactions:
Biotech: 136 Transactions / 43European Transactions
Med Tech: 81 US Transactions / 28 European Transactions
Notable Transactions:
Biogen acquired Reata Pharma - 7/28/2023 for $7.3B or $172.50/share (59% premium)
Novartis acquired DTx Pharma - 7/17/2023 for $500M
Shionogi acquired Qpex Biopharma - 6/26/2023 for $100M
Eli Lilly acquired Dice Therapeutics - 6/20/203 for $2.4B or $48.00/share (42% premium)
Novartis acquired Chinook Therapeutics - 6/12/2023 for $3.2B or $40.00/share (67% premium)
Gurnet Point Capital, Novo Holdings acquired Paratek Pharmaceuticals - 6/6/2023 for $123M or $2.15/share (9% premium)